drugset
Drugs / Gam-COVID-Vac
last change Dec 2023 re-read 2 minutes ago

Gam-COVID-Vac

also known as Sputnik V · SPUTNIK-V (Gam-COVID-Vac)

Vaccine

Developed for
COVID-19
Investigated by
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation · Russian Direct Investment Fund · Acellena Contract Drug Research and Development · CRO: Crocus Medical BV · CRO: JSS Medical Research India Pvt. Ltd. · CRO: iPharma
+4 more · Dr. Reddy's Laboratories Limited · Government of the city of Moscow · Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela · PDC-CRO

Trials 8 · a red edge is where a trial was stopped

today NCT05248373 · Ph 1/2 NCT04656613 · Ph 3 NCT04640233 · Ph 2/3 NCT04642339 · Ph 3 NCT04587219 · Ph 2 NCT04564716 · Ph 3 NCT04530396 · Ph 3 NCT04436471 · Ph 1/2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/22 trials
Phase 1/2 NCT05248373 Mar 2022 → Feb 2023 COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Phase 1/2 NCT04436471 Jun → Aug 2020 — Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Completed No outcome recorded
Phase 21 trial
Phase 2 NCT04587219 Oct 2020 → Mar 2021 COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT04640233 Nov 2020 → Aug 2021 — Dr. Reddy's Laboratories Limited Unknown No outcome recorded
Phase 34 trials
Phase 3 NCT04656613 Dec 2020 → Aug 2021 COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Phase 3 NCT04642339 Nov 2020 → Oct 2021 COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Phase 3 NCT04564716 Sep 2020 → Mar 2021 COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Phase 3 NCT04530396 Sep 2020 → May 2021 — Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Unknown No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04988048 Comparator Aug → Sep 2021 COVID-19 Ministry of Public Health, Argentina Unknown No outcome recorded
Phase 2 NCT04983537 Comparator Jul → Sep 2021 — Ministerio de Salud de Ciudad Autónoma de Buenos Aires Unknown No outcome recorded
Phase 2 NCT04962906 Comparator Jul → Aug 2021 — Ministerio de Salud de Ciudad Autónoma de Buenos Aires Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 13 sources stand behind the page.

FieldValueCited text
Known as Gam-COVID-Vac “Gam-COVID-Vac Gamaleya National Center for Epidemiology and Microbiology - Russia.” NCT04988048 ↗
10

NCT05248373 ↗

NCT04587219 ↗

NCT04530396 ↗

NCT04962906 ↗

NCT04642339 ↗

NCT04656613 ↗

NCT04640233 ↗

NCT04564716 ↗

NCT04983537 ↗

NCT04436471 ↗
Known as Sputnik V “BACKGROUND: A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune...” PMID 33545094 ↗ Feb 2021
Known as SPUTNIK-V (Gam-COVID-Vac) “SPUTNIK-V (Gam-COVID-Vac)” NCT04988048 ↗
Modality Vaccine “adenoviral-based vaccine against SARS-CoV-2” NCT04436471 ↗
Route Intramuscular “administered intramuscularly on day 0 either one dose of rAd26-S or one dose of rAd5-S” PMID 32896291 ↗ Sep 2020